Question.1023 - Chapter 18 and 19 Questions- (3 pts each, except 8 which is worth 10 pts) Imagine someone contracts the flu. Outline the four phases of the immune response to this virus. What is a vaccine and how does getting a vaccine impact immunity for the immunized person and others? A pathogen is a fancy name for germ. Describe the ways pathogens can be transmitted. Bacteria and viruses are both pathogens. Sometimes the symptoms are very similar and it’s difficult to tell if something is a virus (like the flu) or bacteria (like strep throat). Which one could you treat with antibiotics and why? Which can you get a vaccine for – the flu or strep throat? If you live on a college campus, what are 8 steps you can consistently take to avoid illnesses? If you don’t live on campus, what are 8 things you can do in your current living environment to avoid illness? What is HIV and what part of the body does it attack? What makes HIV challenging to treat? How is HIV transmitted? Check out Figure 19.4 in the textbook. What is the riskiest of all sexual behaviors regarding HIV? List 5 factual preventive measures to help prevent STIs. Complete for the following types of STIs (10 pt question)
Answer Below:
Assignment xxxxxxxx and xxxxxxxxx Eric xxxxxxx Central xxxxxxxxx University xx Personal xxx Community xxxxxx Professor xxxx Brackman xxxx rd xxxxxxxxxx Chapters xxx Questions xxx Immune xxxxxxxx to xxx Flu xxxxx Has xxxx Stages x Recognition xxxxx The xxx virus xx recognized xx an xxxxxxxxxxxx intruder xx the xxxxxx system xxxx happens xxxxxxxx the xxxxx penetrates xxx body xxx respiratory xxxxxxxx and xxxxxxxxxx immune xxxxx such xx dendritic xxxxx and xxxxxxxxxxx identify xxx virus's xxxxxxxxx Yang xx al x Activation xxxxx To xxxxxx the xxx virus xxx immune xxxxxx activates xxxxxxx immunological xxxxxxxxx this xx accomplished xx the xxxxxxxxxx of x and x cells xxxx belong xx specialized xxxxx blood xxxxx Yang xx al x cells xxxxxx antibodies xxxx combat xxx flu xxxxx whereas x cells xxxxxxx infected xxxxx directly xxxx et xx c xxxxxxxx Phase xxx immunological xxxxxxxx becomes xxxx intense xxxxxx this xxxxx Yang xx al xxxxxxxxxx tend xx work xx sticking xxxxxxxxxx to xxx flu xxxxxxx in xxx body xxxx that xx does xxx lead xx infecting xxxxx that xxxxxxxx the xxxxx from xxxxxxxxxxx itself xxxxxxxxx T xxxxx then xxxxxxx the xxxxxxxx cells xxx destroy xx Yang xx al x Memory xxxxx Memory x and x cells xxx generated xxxxx the xxxxxxxxx has xxxx eliminated xxx the xxxxx tend xx store xxx memory xx the xxx virus xx terms xx detection xxxx that xxxx can xxxxxxxx if xx encounters xxxx virus xxxxx and xxxxxxxx to xx Yang xx al xxxx Is x Vaccine xxx How xxxx It xxxxxx Immunity xxxxxxxxxxx in xxxxxxx terms xx referred xx as xxx biological xxxxxxxxxxx wherein xx enables xxx body xx identify xxxxxxxxx and xxxxxxxx to xx by xxxxxxxxxxx the xxxxxx system xx develop xxxxxxxxxxxxx responses xxx vaccination xxxxxxx the xxxx to xxxxxxxxx a xxxxxx B xxx T xxxxx such xxxx similar xx identical xxxxxxxxx enters xxx body xx can xxx the xxxxxx memory xx eradicate xx fight xxxx reducing xxx severity xxx also xxxxx herd xxxxxxxx one xxxx example xxxxx be xxxxxx wherein xxx spread xx pathogen xxx restricted xxxxxxx vaccination xxxx immunity xxxxxxxxx Pathogen xxxxxxxxxxxx Pathogens xxx be xxxxxxxxxxx in x variety xx ways xxxxxxxxx a xxxxxx Contact xxxxxxxxx can xx transmitted xx contact xxxx contaminated xxxx fluids xxxx include xxxxx transmission xxxxxx or xxxxxxxx from xxx airway xxxxxxxx et xx Pathogens xxx be xxxxxxxxxxx by xxxxxxx with xxxxxxxx objects xx surfaces xxxxxxxx virus xx bacteria-infected xxxxxxxxx shared xxxxxxxx or xxxxxxxx can xxxxxx in xxxxxxxxxxxx McCallum xx al x Airborne xxxxxxxxxxxx Some xxxxxxxx may xxxxxxxxx in xxx air xxxxxxx respiratory xxxxxxxx and xx breathed xx by xxxxxx infecting xxxx McCallum xx al xxx flu xxxxx and xx bacterium xxx two xxxxxxxx Primarily xxxxxxxxx tend xx be xxxxxx by xxxxxxx who xxxx the xxxxxxxxx to xxxxxxxx the xxxxxxx Vaccines xxx Antibiotics xxxxxxx considering xxxxxxxxxxx that xxxxxx bacterial xxxxxxxxx by xxxxxx killing xx preventing xxx development xx bacteria xxxxxx et xx Secondly xx terms xx vaccines xxxx serve xx preventative xxxxxxx for xxxx supports xxx immune xxxxxx a xxxxxx example xxxxx be xxxxxx wherein xxx vaccination xxx a xxxx strand xx Covid- xxxxx helping xxx body xxxx out xxxxxxxx and xxxxx the xxxxx if xx entered xxxx Vaccination xxx influenza xxxxx is xxxxxxxxxx and xxxxxxxxx but xxx for xxxxx throat xxxxxxxxx infection xxxxxx et xx Streptococcus xxxxxxxx tends xx cause xxxxx throat xxx it xxx be xxxxxxxxxx using xxxxxxxxxxx Mishra xx al xxxxx to xxxxxxxx Illness xxxxxxx of xxxxxxx according xx my xxxxxxxxxxxxx a xxxxxxxx Good xxxxxxx Practices xxxx your xxxxx frequently xxx avoid xxxxxxxx your xxxx b xxxxxxx a xxxxx Living xxxxxxxxxxx Clean xxx disinfect xxxxxxxxx touched xxxxxxxx on x regular xxxxx c xxx Respiratory xxxxxxxxx Covering xxxxxx and xxxxxxx to xxxxxxx respiratory xxxxxxxx from xxxxxxxxx d xxx Vaccinated xxxxxxxx current xxxxxxxxxxxxx particularly xxx flu xxxxxxx e xxxxxxxx Diet xxxxx that xxxx a xxxxxxx of xxx nutritious xxxxxx and xxxxxxx immunity x Exercise xx a xxxxxxx Basis x Get xxxxxxxx Sleep x Limit xxxxxxx with xxx persons xxx is x retrovirus xxxx compromises xxx immune xxxxxx in xxxxx of xx T xxxxx particularly xxxxxx T xxxxx Reeves xxx Doms xxxxx makes xx challenging xxx the xxxx to xxxxx back xxxxxx contact xx through xxxxxx fluids xxxxxxxxx mother xx child xxxxxxxxx Difficulties xx appropriate xxxx since xxx of xx T xxxxx are xxxxxxxx Reeves xxx Doms xxxxxxxxxxx anal xxxxxxxxxxx is xxxxxxxx the xxxxxxxx sexual xxxxxxxx for xxx transmission xxxxxxx the xxxxxx lining xx more xxxxx to xxxx and xxxxxxxxx making xx simpler xxx the xxxxx to xxx into xxx circulation xxx Prevention x Abstinence xxxxx sexual xxxxxxxx to xxxxx STI xxxxxxxxxxxx a xxxxxxxxxx Relationships xxxxxx intimate xxxxxxxxxxxxx and xxxx a xxxxxxxxxxxx that xx monogamous xxxx an xxxxxxxxxx who xxx tested xxxxxxxx for xxxx Reeves xxx Doms x Condom xxx Use xxxxxxxxxxxxxx condoms xxxxxxxxx and xxxxxxxxxxxxx during xxxxxx intercourse xx lower xxx risk xx STI xxxxxxxxxxxx Reeves xxx Doms x Regular xxxxxxx Get xxxxxx for xxxx on x regular xxxxx especially xx you xxx sexually xxxxxx with xxxxxxx partners xxxxxx amp xxxx d xxxxxxxxxxx To xxxxx infection xx immunized xxxxxxx STIs xxxx HPV xxxxx Papillomavirus xxxxxx amp xxxx STI xxxxxxxxx Pathogen xxxxxxxxx trachomatis xxxxxxxx Stages xxxxxxx the xxxx and xxxxxx reproductive xxx urinary xxxxxxx of xxxxxx Linhares xxxxxxxx vaginal xx penile xxxxxxxxx difficult xxxxxxxxx and xxxxxx discomfort xxxxxxxx Rare xxxxxxx symptoms xxx found xx women xxxxxxxx Antibiotics xxxxxxxxxxxx or xxxxxxxxxxx Linhares xxx Gonorrhea xxxxxxxx Neisseria xxxxxxxxxxx Unemo xxx Shafer xxxxxx infects xxxx and xxxxxx reproductive xxx urinary xxxxx mucous xxxxxxxxx in xxxxxxxx to xxx throat xxx rectum xxxxx amp xxxxxx Symptoms xxxxxxxx urinary xxxxx abnormal xxxxxxx discharge xxx in xxxxx and xxxxxxxxxxxx while xxxxxxxxxxxx condition xx the xxxxxxxxxx in xxxxx Unemo xxx Shafer xxxxxxxxxxx ceftriaxone xxx azithromycin xxxxx amp xxxxxx STI xxxxxxx Herpes xxxxxxxx - xxxxxx Simplex xxxxx HSV- xxxx Taylor xx al xxxxxx Genital xxxxxx starts xxxx - xxxxxxx sores xx blisters xx the xxxxxxx region xxxx progressive xxxxxxxxx Taylor xx al xxxxxxxxx No xxxx for xxxxxxx herpes xxxxxx et xx Possibility xxxxxxxxx drugs x acyclovir xxxxxxxxxxxx and xxxxxxxxxxx tend xx reduce xxx outbreak xxxxxx et xx STI xxxxxxxx Bacterium x Treponema xxxxxxxx Pathogen xxxxxxx et xx Stages xxxxxxx A xxxxxxxx chancre xxxxx at xxx site xx infection xxxxxx the xxxxx stage xxxxxxx et xx secondary xxx and xxxxxxxx symptoms xxxxxx amp xxxxxxxx affects xxxxxxxx organs xxx neurological xxx cardiovascular xxxxxxxxx Antibiotics xxxxxx penicillin xxx used xx treat xxxxxxxx Salazar xx al xxxxxxxxxx Castrucci x R xxxxxxx affecting xxxxxx responses xx the xxxxxxxxx vaccine xxxxx vaccines xxx immunotherapeutics x McCallum x Barlow x amp xxxx J xxx should xxxxxxxx transmission xx modelled xxxxxx in xxxxxxx amp xxxxxxxxx - xxxxxx R x Oviedo-Orta x Prachi x Rappuoli x amp xxxxxxx F xxxxxxxx and xxxxxxxxxx resistance xxxxxxx opinion xx microbiology x Reeves x D xxx Doms x W xxxxx immunodeficiency xxxxx type xxxxxxx of xxxxxxx virology x Salazar x C xxxxxxx K x amp xxxxxx J x The xxxxxx response xx infection xxxx Treponema xxxxxxxx the xxxxxxx pathogen xxxxxxxx and xxxxxxxxx - xxxxxx T x Brockman x A xxxxxxx E x amp xxxxx D x Herpes xxxxxxx virus xxxxxxxxx in xxxxxxxxxxxxxxxxxxx - xxxxx M xxx Shafer x M xxxxxxxxxx resistance xx Neisseria xxxxxxxxxxx origin xxxxxxxxx and xxxxxxx learned xxx the xxxxxx Annals xx the xxx York xxxxxxx of xxxxxxxx E xx Witkin x S xxxxx E xxxxxxxxxx A xxxxxx J xxx Linhares x M xxxxxxxxx trachomatis xxx persistent xxxxxxxx Clinical xxx Vaccine xxxxxxxxxx e x Yang x Liu x Du x amp xxxxx S x new xxxx of xxxxxxxxxxxxx NA xx the xxxxxxxxx virus xxxx cycle xxxxxxxxxxx for xxxxxxxxxx NA xxxxxxxxxx with xxxxx mechanism xx action xxxxxxx in xxxxxxx Virology xMore Articles From Physiology
.ico)
.ico)
.ico)
.ico)
